Skip to main content
. 2014 Mar;58(3):1744–1748. doi: 10.1128/AAC.02135-13

FIG 3.

FIG 3

Impact of the different cefquinome dosage regimens on the proportion of cefotaxime-resistant Enterobacteriaceae in the fecal flora of rats before, during, and after treatment. ⧫, Patent-phase-adjusted dose (50 mg/kg); □, prepatent-phase-adjusted dose (5 mg/kg); Inline graphic, control untreated group. Data are means ± SDs. The arrows indicate the days of antibiotic administration.